Tapping the Unused Potential of Photosynthesis with a Heterologous Electron Sink by Berepiki, A. et al.
This is an author produced version of Tapping the Unused Potential of Photosynthesis with
a Heterologous Electron Sink.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/124121/
Article:
Berepiki, A., Hitchcock, A., Moore, C.M. et al. (1 more author) (2016) Tapping the Unused 
Potential of Photosynthesis with a Heterologous Electron Sink. ACS Synthetic Biology, 5 
(12). pp. 1369-1375. ISSN 2161-5063 
https://doi.org/10.1021/acssynbio.6b00100
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
1 
 
Tapping the unused potential of photosynthesis with a 1 
heterologous electron sink 2 
 3 
Adokiye Berepiki*, Andrew HitchcockÁ, C. Mark Moore & Thomas 4 
S. Bibby* 5 
2FHDQDQG(DUWK6FLHQFHV1DWLRQDO2FHDQRJUDSK\&HQWUH8QLYHUVLW\RI6RXWKDPSWRQ8. 6 
Á'HSDUWPHQWof Molecular Biology and Biotechnology, University of Sheffield, UK 7 
 8 
 9 
  10 
2 
 
Abstract 11 
Increasing the efficiency of the conversion of light energy to products by 12 
photosynthesis represents a grand challenge in biotechnology.  Photosynthesis is 13 
limited by the carbon-fixing enzyme Rubisco resulting in much of the absorbed 14 
energy being wasted as heat, fluorescence or lost as excess reductant via alternative 15 
electron dissipation pathways. To harness this wasted reductant, we engineered the 16 
model cyanobacterium Synechococcus PCC 7002 to express the mammalian 17 
cytochrome P450 CYP1A1 to serve as an artificial electron sink for excess electrons 18 
derived from light-catalysed water-splitting. This improved photosynthetic efficiency 19 
by increasing the maximum rate of photosynthetic electron flow by 31.3%. A simple 20 
fluorescent assay for CYP1A1 activity demonstrated that the P450 was functional in 21 
the absence of its native reductase, that activity was light-dependent and scaled with 22 
irradiance. We show for the first time in live cells that photosynthetic reductant can be 23 
redirected to power a heterologous cytochrome P450. Furthermore, PCC 7002 24 
expressing CYP1A1 degraded the herbicide atrazine, which is a widespread 25 
environmental pollutant.  26 
 27 
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Photosynthesis is the pivotal biochemical reaction on the planet, providing energy for the 30 
global ecosystem. The evolution of oxygenic photosynthesis 2.7-3.2 billion years ago led to 31 
the oxygenation of the planet.1  This subsequently hampered the efficiency of 32 
photosynthesis as oxygen competed for binding to the active site of the carbon-fixing 33 
catalyst ribulose-1, 5-bisphosphate carboxylase/oxygenase (Rubisco). As a result, the 34 
potential of photosynthesis is not achieved as the capacity for light capture and electron 35 
transport is often greater than the capacity for carbon-fixation. Photosynthetic cells therefore 36 
lose excess energy as heat and fluorescence, or through a number of alternative electron 37 
dissipation pathways.2 Improving photosynthetic efficiency is central to efforts to increase 38 
food and/or biofuel yield, and also to realize the biotechnological potential of photosynthetic 39 
species.3  These efforts typically focus on modification of the pigments and proteins involved 40 
in light capture, improving the efficiency/specificity of Rubisco or metabolic engineering of 41 
product formation downstream of carbon fixation.4  However, rewiring photosynthesis such 42 
that excess reducing potential from light capture is diverted to catalyse the formation of high 43 
value products has received little attention.5 Such a strategy can, in theory, increase the 44 
overall efficiency of photosynthetic electron usage by enabling the utilisation of electrons that 45 
would otherwise be wasted.   46 
 To increase overall photosynthetic efficiency, we installed the P450 CYP1A1 from 47 
Rattus norvegicus (brown rat) into Synechococcus PCC 7002 (henceforth Synechococcus) 48 
as a new electron-sink in the photosynthetic electron transport chain (Figure 1a). 49 
Cytochrome P450s are a large and diverse class of monooxygenases that split molecular 50 
oxygen (O2), inserting one atom into the substrate and reducing the other to water (Figure 51 
1a). CYP1A1 plays a key role in the biotransformation of drugs and other chemical 52 
compounds in mammals and has been widely studied. The catalytic activity of CYP1A1 is 53 
well-defined and easily assayed,6 its structure has been resolved at 2.6 Å7 and it has been 54 
expressed in other microbial hosts, allowing comparison of expression and activity levels 55 
among species.8 We designed plasmid pSy21 to express CYP1A1 in Synechococcus. The 56 
expression cassette consisted of the cyp1a1 gene, a constitutive phycocyanin promoter from 57 
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Synechocystis PCC 6803, a kanamycin resistance cassette, the rrnB terminator from 58 
Escherichia coli, and targeting flanks to guide integration to the glpK genomic neutral site 59 
(Figure 1b). The cyp1a1 gene was codon-optimized for expression in Synechococcus and 60 
the FLAG peptide sequence was added in-frame, along with a 4 x glycine-alanine peptide 61 
linker, to the 3' of cyp1a1 to simplify detection, quantification and purification; no other 62 
modifications were made to the cyp1a1 sequence. This multipart construct was assembled 63 
in one step by in vivo recombination in Saccharomyces cerevisiae.9  64 
 Wild-type (WT) Synechococcus was transformed with pSy21 and, following 65 
segregation by serially sub-culturing transformants under kanamycin selection, genotyping 66 
by colony PCR confirmed that clones transformed with pSy21 were homozygous (Figure 1c). 67 
Expression of CYP1A1 was demonstrated by immunoblotting with an anti-FLAG antibody 68 
(Figure 1d) and the new strain was designated Sy21. CYP1A1 was present as a single band 69 
corresponding to its predicted molecular weight of 61 kDa. No degradation products were 70 
observed, showing that the recombinant protein was stable.  71 
 Eukaryotic P450s are generally integral membrane proteins anchored via an N-72 
terminal transmembrane domain and require a lipid-rich environment for full activity.10   73 
CYP1A1 was found in the thylakoid fraction (Figure 1e), demonstrating that the native N-74 
terminal membrane targeting domain of CYP1A1 is sufficient for localisation to the thylakoid 75 
membrane of Synechococcus. This feature is relevant as expression of recombinant 76 
membrane proteins in bacterial hosts is notoriously troublesome11 and demonstrates that 77 
Synechococcus may be a useful production host for heterologous P450s due to the 78 
presence of internal thylakoid membranes as a platform for membrane protein expression, a 79 
strongly reducing cellular environment, and oxygenic metabolism to provide the O2 needed 80 
for P450 catalysis.  81 
  Activity of CYP1A1 was determined by an ethoxyresorufin O-deethylation (EROD) 82 
assay, which is a rapid and sensitive means of assessing CYP1A1 activity, based on 83 
production of the fluorescent compound resorufin from ethoxyresorufin in live cells.6 EROD 84 
demonstrated that CYP1A1 is active in Synechococcus (Figure 2a). CYP1A1 was active in 85 
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the absence of its native POR (P450 oxidoreductase), which suggests that reducing 86 
equivalents may have been derived from the photosynthetic machinery, potentially via 87 
ferredoxin (Figure 1a). A reductant with a midpoint redox potential similar to or more 88 
negative than NADPH (-324 mv) is required to support P450 activity. Thus the midpoint 89 
redox potential of cyanobacterial ferredoxins of between -325 and -390 mV,12  is sufficient to 90 
reduce the P450.  Indeed, it has been shown with in vitro experiments using chloroplasts or 91 
purified thylakoids and spinach ferredoxin that electrons derived from photosystem I (PSI) 92 
can be redirected to heterologous P450s to provide reducing equivalents in a light-93 
dependent manner.5, 13-17 In these in vitro experiments, ferredoxin serves as the electron 94 
donor instead of NADPH.  95 
To determine the source of reducing equivalents, cells were treated with DCMU (3-96 
(3,4-dichlorophenyl)-1,1-dimethylurea) which is a specific inhibitor of photosystem II (PSII) 97 
electron flow.18 Treatment with 5 µM DCMU reduced resorufin production during the EROD 98 
assay by 71.4% (Figure 2b). This finding demonstrates that the majority of electrons utilized 99 
by CYP1A1 are derived via PSII-catalysed photosynthetic linear electron flow. Although 100 
DCMU prevents linear electron flow from PSII, electron transport from other pathways such 101 
as cyclic electron flow or respiration is still possible. The remaining P450 activity upon 102 
treatment with DCMU may therefore be supported by electrons from the respiratory chain 103 
which shares a b6f complex with photosynthesis and under illumination can result in 104 
respiratory electrons being used by PSI to reduce ferredoxin.2  105 
To show that P450 activity was light-dependent, cells were kept in the dark during the 106 
EROD assay. In the absence of light, resorufin production was reduced by 96.8% (Figure 107 
2b), clearly showing that CYP1A1 activity is almost entirely light dependent in Sy21. This is 108 
further evidence for the involvement of PSI in transferring electrons to the P450, as the 109 
reduction of activity is greater in the dark than that caused by PSII inhibition alone with 110 
DCMU.   111 
To explicitly demonstrate that CYP1A1 activity is light-driven, we determined the 112 
irradiance dependence of CYP1A1 activity by EROD in vivo. Cells were illuminated at 113 
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irradiances ranging from 0 to 213 µmol photons m-2 s-1, revealing a saturating dependence of 114 
CYP1A1 activity (Figure 2c), suggesting a response that was dependent on the production of 115 
reducing equivalents from the cellular photosynthetic machinery. Although previous work has 116 
shown light-powered P450 activity using in vitro enzyme assays on thylakoid preparations,5, 117 
13-17
 our finding provides the first direct evidence in live cells that photosynthetic reductant 118 
can be redirected to power a heterologous P450. Additionally, by functionally coupling an 119 
easily assayed P450 to the photosynthetic machinery we have developed a unique in vivo 120 
biosensor for light-generated reducing power.  121 
Synechococcus cultures in these experiments were maintained at a light irradiance of 122 
200 µmol photons m-2 s-1; its optimal light irradiance is 275 µmol photons m-2 s-1 and growth 123 
rates do not increase linearly with irradiance beyond this light level.19 However, the 124 
saturation light intensity for CYP1A1 was 29 µmol photons m-2 s-1 (Figure 2c). Thus, at 125 
physiologically relevant light irradiances P450 activity can be saturated in our expression 126 
system. This finding suggests that P450 expression does not require potentially damaging 127 
light intensities to generate measurable activity.  128 
 It has been shown previously that expression of cytochrome P450s can be used to 129 
increase resistance to herbicides.20, 21 CYP1A1 enhances the resistance of tobacco to the 130 
potent herbicides atrazine and chloroturon and has been shown to degrade a range of 131 
polycyclic aromatic hydrocarbons demonstrating its potential for bioremediation.20, 22 Atrazine 132 
is one of the most heavily used pesticides worldwide and is particularly problematic as an 133 
environmental pollutant because it is widespread, can persist for decades, is commonly 134 
found in drinking water and has been associated with potential endocrine and carcionogenic 135 
activity.23  To ascertain whether expression of CYP1A1 increased resistance to atrazine, 136 
sensitivity testing was performed on solid media. Similar to other trizines, atrazine inhibits 137 
photoautotrophic growth by binding to the D1 protein in PSII and preventing reduction of 138 
plastoquinone.18 The lethal dose of atrazine for Synechococcus is 1.5 µg ml-1.24 Atrazine 139 
sensitivity testing of WT Synechococcus and Sy21, showed that Sy21 is able to grow at 140 
atrazine concentrations of 1.5 µg ml-1 whereas the WT failed to produce chlorophyll and 141 
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remained unpigmented showing a cessation of photoautotrophic growth and a physiological 142 
stress response (Figure 2d). Thus, CYP1A1 enhances resistance to the herbicide atrazine.  143 
This feature can be exploited in subsequent screens to engineer both the host and the 144 
enzyme to support increased P450 activity. Importantly, this finding demonstrates that 145 
cyanobacteria can be modified for enhanced resistance to, and the ability to degrade, 146 
environmental pollutants, which, given the ubiquity and abundance of Synechococcus spp.,25 147 
is worthy of further investigation.  148 
The fact that CYP1A1 has been expressed in other microbial systems allowed us to 149 
compare light-driven CYP1A1 activity to that powered via NAPDH and a POR in 150 
heterotrophic organisms such as E. coli and S. cerevisiae (Table 1). Light-powered CYP1A1 151 
activity is 0.031 µmol min-1 gdcw-1, (gram dry cell weight), which is ~15 fold lower than that 152 
reported for E. coli but only ~5 fold lower than S. cerevisiae.8  We quantified CYP1A1 in our 153 
expression system by immunoblotting using commercially available bacterial alkaline 154 
phosphatase-FLAG (BAP-FLAG) as standard (Supplementary figure 1). CYP1A1 155 
concentration was 6.2 pmol mg-1 total protein (0.38 µg mg-1 of total protein) in strain Sy21, 156 
which is comparable to thDWDFKLHYHGLQWREDFFRSPROPJ-1)21 but 33-fold less than 157 
observed in yeast microsomes (21 nmol mg-1 protein).26 Therefore, it is likely that higher 158 
CYP1A1 activity could be achieved  through better timing and fine-tuning of expression using 159 
strong inducible promoters.27 Additionally, as the electron transport chain driving CYP1A1 160 
activity competes with other electron acceptors for ferredoxin it is expected that activity will 161 
be enhanced through protein engineering to optimize the interaction between CYP1A1 and 162 
ferredoxin or by a direct fusion to ferredoxin, as has been shown recently for CYP79A1.28 163 
For light-powered P450-mediated biotransformations to be economically feasible a 164 
volumetric productivity of 0.001 g l-1 h-1 (equal to 0.006 µmol min-1 gdcw-1) is required for 165 
pharmaceuticals and drug metabolites.8, 29 Thus, the activity achieved for light-driven P450 166 
activity (0.031 µmol min-1 gdcw-1) is 5-fold more than that required. However, commercial 167 
production of fine chemicals, given their lower economic value, require much higher 168 
productivities of 0.1 g l-1 h-1 (equal to 0.6 µmol min-1 gdcw-1),8, 29 which is 19-fold less than that 169 
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achieved for light- powered CYP1A1. Although light-driven CYP1A1 activity is less than that 170 
reported in other hosts, it is comparable and demonstrates the potential of Synechococcus 171 
as a production host. Indeed, a recent report has demonstrated that cyanobacteria can 172 
express multiple, active P450s.15 173 
If, as we suggest, CYP1A1 is being powered by photosynthetic reductant, we might 174 
expect that activity of the P450 would function as an artificial electron sink, increasing the 175 
light saturation level of photosynthesis and associated optimal irradiance levels. 176 
Physiological parameters were assessed using Fast Repetition Rate fluorometry30 (FRRf) to 177 
determine the effects of CYP1A1 on the characteristics of the photosynthetic electron 178 
transport chain. The chlorophyll a content and functional absorption cross sections of PSII 179 
ıPSII) were similar in the WT and Sy21 (Table 2) consistent with CYP1A1 expression having 180 
minimal direct impact on photosynthetic organisation.  The apparent photosynthetic energy 181 
conversion efficiency (Fv/Fm) is slightly elevated in Sy21 suggesting it is using light energy 182 
more effectivity, however this does not result in an increase in growth rate which remains 183 
similar to WT (Figure 3a). Moreover, the maintained growth rates suggest that P450 activity 184 
does not significantly deplete the cell of reducing equivalents required for growth and 185 
maintenance. Importantly, Sy21 had a 31.3% higher maximum PSII electron transport rate 186 
(ETRmax; Table 2 and Figure 3b) and correspondingly a 38.2% higher light saturation 187 
intensity (Ek) than the WT, demonstrating the increased capacity of Sy21 to process 188 
photosynthetically derived electrons. This finding also demonstrates that the expressed 189 
P450 can reduce endogenous substrates, which is unsurprising given the range of 190 
compounds CYP1A1 is able to act upon.7, 22 Moreover, treatment of cells with 10 µM of the 191 
P450 LQKLELWRUĮ-naphthoflavone,31 which completely abrogated CYP1A1 activity in strain 192 
Sy21 (Supplementary Figure 2), reduced both ETRmax and Ek to WT levels in Sy21, while 193 
having minimal effect on the WT (Figure 3b).  Thus, rather than competing with the 194 
photosynthetic dark reactions for reductant and hence potentially suppressing overall growth 195 
rates, the expression and activity of CYP1A1 acts as a significant additional sink for 196 
electrons downstream of PSII. Enhanced linear photosynthetic electron transport was thus 197 
9 
 
maintained at saturating light intensities by the re-direction of excess electrons to CYP1A1. 198 
As light-powered P450 activity is concomitant with the irreversible hydroxylation of a 199 
substrate it is therefore distinct from native dissipative electron sinks such as water-water 200 
cycles catalysed by Flv1/3 enzymes.32 The increase in maximum electron flux in Sy21 raises 201 
the possibility that light-powered P450 activity will contribute to enhanced proton motive 202 
force and ATP generation, however, this possibility requires further experimental validation. 203 
In summary, we have expressed a mammalian P450 in a cyanobacterial host and 204 
demonstrated with a simple fluorescent assay in live cells that its activity was light-205 
dependent and scaled with irradiance. The P450 is active in the absence of its native 206 
reductase, is dependent on electrons derived from photosynthesis and confers resistance to 207 
the herbicide atrazine. Hence, this paper describes how a widespread and important aquatic 208 
microbe may be genetically engineered for the light-driven bioremediation of environmental 209 
pollutants. Importantly, expression of CYP1A1 increased the optimal level of irradiance for 210 
photosynthetic electron transport meaning that at supra-optimal irradiances electrons that 211 
would otherwise be wasted are now redirected to power product formation by a heterologous 212 
enzyme. Therefore, we have re-engineered photosynthesis such that new products can be 213 
formed independently of the inherent catalytic limitations of Rubisco. This study represents 214 
the first demonstration of a highly-promising strategy to improve the overall efficiency of 215 
electron use during photosynthesis at supersaturating irradiances for the production of clean 216 
and sustainable biomolecules and should be applicable to any photosynthetic species. 217 
 218 
 219 
  220 
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 221 
Methods  222 
Chemicals. Water was from a Milli-Q filtration system (Millipore). Chemicals used in this 223 
study were purchased from Sigma, Invitrogen or Fisher. Antibiotics were purchased from 224 
Sigma or Melford Biolabs. Plasmid DNA was purified with mini-prep kits from Zymo 225 
Research. Q5 polymerase was purchased from New England Biolabs and was used for all 226 
PCRs with the exception of colony PCRs which were carried out using Phire Green Hot Start 227 
II polymerase from Thermo Scientific. FastDigest restriction enzymes were purchased from 228 
Thermo Scientific.  229 
 230 
Culture conditions. Escherichia coli strain XL1 blue was used for cloning purposes and 231 
plasmid maintenance and was grown in LB containing the appropriate antibiotic (kanamycin 232 
50 µg ml-1). For in vivo recombination the S. cerevisiae strain FY834 was used and grown in 233 
YPD or SC-uracil.  234 
WT Synechococcus PCC 7002 was obtained from the National Center for Marine 235 
Algae and Microbiota (Bigelow Laboratory for Ocean Sciences, Maine). WT and engineered 236 
strains of Synechococcus were grown in A+ medium containing sodium nitrate (1 g l-1) 237 
supplemented with kanamycin at 100 µg ml-1 where appropriate. Solid A+ media was made 238 
with 1% bacto-agar and 1 mM sodium thiosulfate. For expression studies and analysis of 239 
growth rates, strains were grown in 40 ml of liquid medium in 250 ml baffled flasks; 240 
cultivation was under continuous white LED illumination at 200 µmol photons m-2 s-1 at 37 ºC 241 
with shaking at 200 rpm in an algaetron growth chamber (PSI Instruments). To determine 242 
growth rates, OD730 nm was measured every 24 h for 6 days with a spectrophotometer (model 243 
7315, Jenway). These conditions are referred to as standard growth conditions. Illumination 244 
irradiance was monitored with a Li-Cor Li-250A light sensor equipped with a LI-190SA 245 
quantum sensor. Transformation plates and atrazine-supplemented plates were incubated in 246 
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a multitron growth chamber (Infors AG) with continuous cool white fluorescent illumination at 247 
50-70 µmol photons m-2 s-1 at 30 ºC.  248 
 249 
Ethoxyresorufin O-deethylation (EROD) assay for CYP1A1 activity. CYP1A1 activity 250 
was measured using an EROD assay.6 Cells from an exponentially growing culture were 251 
adjusted to OD730 nm 1.0 with A+ medium and 100 µl of the suspension was dispensed in 252 
triplicate to a black 96-well microplate (Grenier Bio-One) and allowed to equilibrate for 10 253 
min under standard growth conditions. EROD was started by the addition of 100 µl of 5 µM 254 
7-ethoxyresorufin in A+ medium to a final concentration of 2.5 µM. The formation of the 255 
fluorescent product resorufin was measured in a microplate reader (excitation 544 nm, 256 
emission 590 nm; Fluostar Optima by BMG Labtech). For inhibitor studies, DCMU was 257 
dissolved in ethanol and used at 5 µM and the CYP1A1 inhibitor Į-naphthoflavone was 258 
dissolved in DMSO and used at 10 µM. Inhibitors were added to cells at the same point as 259 
7-ethoxyresorufin. 260 
The effect of DCMU and light irradiance on CYP1A1 activity was determined using 261 
the EROD assay with the following modifications. Cells were prepared and dispensed into a 262 
microplate as describe above, covered in foil to exclude light then incubated in standard 263 
conditions for 1 h. This step serves to oxidize the electron transport chain and deplete 264 
cellular reducing equivalents.  The assay was commenced by the addition of EROD as 265 
described above and where appropriate the light intensity was varied using layers of neutral 266 
density paper overlaid on the appropriate wells to yield a range of irradiance from 16-213 267 
µmol photons m-2 s-1. Samples to remain in the dark were covered with foil. Exposure of the 268 
samples to light was minimized throughout the experiment and resorufin production was 269 
measured as described above. 270 
To convert fluorescent units from the plate reader to resorufin formation, a standard 271 
curve was generated using commercially available resorufin (Sigma). Specific activity was 272 
determined by calculating the rate of product formation between two time intervals - 30 and 273 
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60 min - where the rate of product formation was constant.  Activity is given as µmol 274 
resorufin min-1 gdcw-1. 275 
 276 
Biophysical measurements. Samples from exponentially growing cultures (OD730 nm 0.6-277 
0.7) were measured on a FastOcean sensor integrated with a Act2 Laboratory system 278 
(Chelsea Technologies Group Ltd.) using the FRRf technique.30 All samples were dark 279 
acclimated for 30 min prior to analysis. Fluorescence transients were measured through 280 
excitation by 450 nm and 624 nm LEDs to excite both chlorophyll a and phycocyanin 281 
simultaneously using a saturating sequence of 100 1 µs flashlets at a 2 µs repetition rate. 282 
Measurements of fluorescence parameters over an imposed actinic light gradient 283 
(Fluorescence Light Curves, FLCs), were subsequently used to determine light response of 284 
photosynthetic electron transport.33 The FLC consisted of 16 steps, ranging from 0-1600 285 
µmol photons m-2 s-1. Fluorescence transients were fitted to a model30 using the Act2 286 
software to determine the maximum quantum yield for PSII as the ratio of variable to 287 
maximal fluorescence (Fv/Fm) and the functional absorption cross section serving PSII 288 
SKRWRFKHPLVWU\ıPSII) in the dark, alongside the absolute electron transport rate (ETR) 289 
through PSII: 290 
 291 
ETR = ıPSII (Fq¶/Fm¶) / (Fv/Fm) 292 
 293 
where Fq¶/Fm¶ is the ratio of variable to maximal fluorescence measured under actinic light. 294 
The light response of ETR was subsequently fitted to a standard model to derive the 295 
maximum PSII electron transport rate (ETRmax) and the light saturation parameter (Ek). 296 
 297 
Molecular cloning, Immunoblotting and quantification of CYP1A1, Thylakoid 298 
preparation, Dry cell weight determination, Chlorophyll-a measurement. See 299 
Supporting Information for details. 300 
  301 
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Tables 302 
Table 1. Comparison of maximum specific ethoxyresorufin O-deethylation activities (µmol 303 
min-1 gdcw-1) in different recombinant microorganisms expressing CYP1A1. 304 
 305 
Host µmol min-1 gdcw-1 Ref. 
Synechococcus 0.031 this study 
E. coli 0.43 8 
S. cerevisiae 0.16 8 
 306 
 307 
Table 2. Comparison of chlorophyll a content, Fv/FmıPSII, and electron transport rate in the 308 
WT and Sy21.  309 
 310 
Strain chlorophyll a   
(µg ml-1 OD730 nm-1) 
photosynthetic energy 
conversion efficiency 
(Fv/Fm) 
PSII functional 
absorption cross section  
ıPSII) 
Maximum electron 
transport rate 
(e- RCII-1 s-1) 
WT 4.90 ± 0.17 0.414 ± 0.002 2.50 ± 0.05 356.6 
Sy21 4.84 ± 0.26 0.436 ± 0.011 2.48 ± 0.03 468.3 
 311 
  312 
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 313 
Associated content 314 
Supporting information 315 
Primers for PCR are presented in Supplementary Table 1; Quantification of CYP1A1 and 316 
CYP1A1 inhibitor analysis are shown in Supplementary Figure 1 and 2, respectively. 317 
Methods for molecular cloning, immunoblotting and quantification of CYP1A1, thylakoid 318 
preparation, dry cell weight determination, and chlorophyll-a measurement are supplied as 319 
Supporting Information. 320 
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Figure legends 341 
 342 
Figure 1. Expression and localisation of CYP1A1 in Synechococcus. (a) Diagram of an 343 
artificial electron transport chain that uses light to power a heterologous P450. 344 
Photosynthetic electrons derived from water splitting at photosystem II (PSII; not shown) are 345 
used by photosystem I (PSI) to reduce ferredoxin (Fd), which potentially serves as the 346 
electron donor for the P450. (b) Diagram showing the CYP1A1 expression cassette and the 347 
genomic neutral site for integration. (c) Colony PCR on WT and transformed (c1-4) 348 
Synechococcus colonies using primer pair NS1 seg fw and NS1 seg rv. The band sizes 349 
correlate with the expected sizes of 4048 bp for transformants and 397 bp for the WT. (d) 350 
Immunoblot with anti-FLAG antibody on 30 µg of total protein from WT and strain Sy21. 351 
CYP1A1 was detected at the predicted mass of 61 kDa as indicated by the arrow. The lower 352 
panel is SYPRO ruby staining of a duplicate protein gel showing equal loading of each lane. 353 
(e) Immunoblot with anti-FLAG antibody on thylakoids extracted from the WT and Sy21. For 354 
each sample 30 µg protein was loaded. The arrow indicates CYP1A1. 355 
 356 
Figure 2. CYP1A1 activity depends on reducing equivalents from photosystem II (PSII), is 357 
proportional to light irradiance and enhances resistance to atrazine. CYP1A1 activity was 358 
measured via an ethoxyresorufin O-deethylation (EROD) assay in live cells using a 359 
microplate reader. CYP1A1 catalyses the formation of the fluorescent product resorufin from 360 
the non-fluorescent substrate ethoxyresorufin. Measurements were made on three biological 361 
replicates 1 h after the addition of 5 µM ethoxyresorufin. Each experiment was repeated a 362 
minimum of three times and results from a typical experiment are shown. Error bars 363 
represent the standard error of triplicate measurements. Statistical significances were 364 
LQIHUUHGE\WKH6WXGHQW¶Vt test; ***P < 0.001. (a) CYP1A1 activity in WT and Sy21. (b) 365 
CYP1A1 activity in the absence of PSII activity or light. Cells were dark adapted for 1 h to 366 
deplete reducing equivalents then treated with the PSII inhibitor DCMU (3-(3,4-367 
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dichlorophenyl)-1,1-dimethylurea) or kept in the dark. (c) CYP1A1 activity at different light 368 
irradiances. Cells were dark adapted for 1 h to deplete reducing equivalents then illuminated 369 
at different irradiances. Standard curve analysis showed the saturating irradiance for 370 
CYP1A1 activity was 29 µmol photons m-2 s-1. (d) Expression of CYP1A1 increases 371 
resistance to the herbicide atrazine (atz). Sensitivity was assessed by spot testing on solid 372 
media containing 0, 0.5, 1 or 1.5 µg ml-1 atz. Plates were incubated at 30 ºC for 7 days with 373 
illumination at 200 µmol photons m-2 s-1. The cell number for the spots in each panel are, 374 
from left to right, 2 x 105, 1 x 104 and 5 x 102.  375 
 376 
Figure 3. Expression of CYP1A1 increases the optimal irradiance for photosynthesis. Data 377 
are the average of three independent experiments. Error bars represent the standard error of 378 
triplicate measurements. (a) Comparison of growth rate of WT to Sy21. (b) The absolute 379 
electron transport rate from the reaction center of photosystem II (e- RCII-1 s-1) for WT and 380 
Sy21 at different irradiances assessed via Fast Repetition Rate fluorometry (FRRf). Cells 381 
ZHUHWUHDWHGZLWK0RIWKH&<3$LQKLELWRUĮ-naphthoflavone or the diluent control 382 
DMSO. 383 
 384 
 385 
  386 
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Supporting Information 1 
Supplementary Table 1. Primers used to construct the CYP1A1 expression vector and for 2 
genotyping analysis. 3 
Primer name QXFOHRWLGHVHTXHQFH¶-¶ 
NS1 LF fw LL ext ACGCGCCCTGACGGGCTTGTCTGCTCGTTTAAACtgaagcgattggctatgatctacc 
NS1 LF rv TTCTATCGCCTTCTTGACGAGTTCTTCTGAAGATCTttttgatgggccatggtcat 
Kan fw tcagaagaactcgtcaagaaggcg 
Kan rv tggacagcaagcgaaccgga 
Pcpcb fw kan ext CAATTCCGGTTCGCTTGCTGTCCAAGATCTgttataaaataaacttaacaaatctatacc 
Pcpcb rv 6H ext TGCGGCCGCATGGTGATGGTGATGATGCATtgaattaatctcctacttgactttatg 
TrrnB fw Pcpcb ext ACTCATAAAGTCAAGTAGGAGATTAATTCAatgcatcatcaccatcaccatgc 
TrrnB rv NS1 RF ext ACGATTACCAGTGGTACCGAGGTCTAACGCcctaggagcggatacatatttgaatg 
NS1 RF fw TrrnB ext AATACATTCAAATATGTATCCGCTCCTAGGgcgttagacctcggtaccac 
NS1 RF rv RR ext GAAGATCCTTTGATCTTTTCTACGGGGTTTAAACgctcgactgcaccgttgg 
NS1 seg fw tttggatcgttggcagttgg 
NS1 seg rv tgttgacgacctgttgcatg 
 4 
Bases that serve as extensions to guide recombination and are not complementary are 5 
shown in uppercase. 6 
 7 
Molecular cloning. All primers used in this study are listed in Supplementary Table 1 and 8 
PCRs were run using the manufacturers cycling conditions. WT Synechococcus genomic 9 
DNA was used as a template to amplify genomic sequences. 10 
Expression cassettes for Synechococcus were generated by in vivo recombination in 11 
yeast and were designed to integrate into the glpK pseudogene (SYNPCC7002_A2842). All 12 
DNA fragments used were generated by PCR or from synthetic DNA. To generate targeting 13 
flanks, two ׽0.5 kb regions were amplified from glpK using primer pair NS1 LF fw LL ext and 14 
NS1 LF rv for the left flank and primer pair NS1 RF fw TrrnB ext and NS1 RF rv RR ext for 15 
the right flank. The kanamycin selection marker was amplified from pGFP::hph::loxP with 16 
primer pair  kan fw and kan rv. The cpcBA promoter was amplified from WT Synechocystis 17 
PCC 6803 using the primer pair Pcpcb fw kan ext and Pcpcb rv 6H ext. The E. coli rrnB 18 
2 
 
terminator was amplified from pDF-lac with primer pair TrrnB fw Pcpcb ext and TrrnB rv NS1 19 
RF ext. The cyp1a1 gene (NCBI reference: NM_012540.2) from R. norvegicus was modified 20 
to include the FLAG epitope at the C-terminus, codon-optimized for expression in 21 
Synechococcus and synthesized by GeneArt (Thermo Scientific). The cyp1a1 gene and 22 
FLAG sequence are fused by a 4 x glycine-alanine linker. The pKU acceptor vector, into 23 
which the DNA fragments were recombined, was linearized by PCR with primer pair pKU LL 24 
rv and pKU RR fw. The amplicons generated have 30 bp extensions at the 5' and 3'-end that 25 
permit recombination with the adjacent amplicon. Amplicons consisting of targeting flanks, a 26 
selection marker, promoter, CYP1A1 and terminator were co-transformed into yeast, along 27 
with the linearized acceptor vector pKU, for assembly via its endogenous recombination 28 
system.9 Yeast transformations were carried out with the lithium acetate/PEG method and 29 
grown in 20 ml of SC-uracil for selection. The assembled plasmid was transferred from yeast 30 
to E. coli and following restriction digest screening and confirmation of the correct vectors by 31 
DNA sequencing, the cassette was released from the backbone by digestion with PmeI and 32 
transformed into Synechococcus by adding the DNA (~ 1 µg) to 3 ml of cells in exponential 33 
growth phase (OD730 nm 0.6-0.7). After 16-18 h under standard growth conditions cell were 34 
plated out. Single colonies from transformation plates were serially sub-cultured in liquid 35 
medium under standard growth conditions to obtain fully segregated strains. Integration and 36 
segregation was confirmed by colony PCR using primers NS1 seg fw and NS1 seg rv.  Two 37 
independent transformants, Sy21a and Sy21b, were selected and cryopreserved. No 38 
differences in CYP1A1 expression were observed between these transformants (data not 39 
shown).  All experiments were carried out on Sy21a, which was renamed as Sy21.  40 
 41 
Immunoblotting and quantification of CYP1A1. Whole cell extracts of Synechococcus 42 
strains were prepared from 40 ml cultures. Cells were harvested by centrifugation at 3,500 g 43 
for 10 min at room temperature (RT; 21 °C). Approximately 100 mg of 0.1 mm zirconia 44 
beads (Biospec Products) was added to the pellet followed by the addition of an equal 45 
volume (~ 300 µl) of SDS lysis buffer (200 mM NaCl, 25 mM EDTA, 0.5% (w/v) SDS, 200 46 
3 
 
mM Tris-Cl, pH 8.5). The cells were lysed in a Tissue lyser (Qiagen) for 2 x 30 s cycles at a 47 
frequency of 30 Hz. The tubes were then heated to 95 °C in a heat block for 10 min, cooled 48 
briefly on ice then cell debris was pelleted by centrifugation at 17,000 g for 10 min at 4 °C. 49 
The cleared lysate was removed and quantified for total protein using a bicinchoninic acid 50 
(BCA) protein assay (Pierce) with bovine serum albumin (BSA) as the standard. We used 51 
BAP conjugated to the FLAG peptide at the C-terminus (BAP-FLAG) as a standard for 52 
quantitative immunoblots. BAP-FLAG was quantified in the same manner as whole cell 53 
extracts and then diluted in a 1 mg ml-1 solution of BSA, which minimizes nonspecific binding 54 
of the protein standard to plasticware. Protein samples were prepared in LDS loading buffer 55 
(Invitrogen) containing DTT at 50 mM and heated for 10 min at 70 °C. Thirty micrograms of 56 
total protein was separated by electrophoresis on a 4-12% gradient Bis-tris NuPAGE gel in 57 
MES buffer (Invitrogen) in a Novex XCell SureLock Mini Cell (Invitrogen) for 35 min at 200 V. 58 
Where appropriate, BAP-FLAG standard was loaded in amounts ranging from 2-10 ng. Gels 59 
were then stained for total protein using SYPRO Ruby (Invitrogen), according to the 60 
PDQXIDFWXUHU¶VLQVWUXFWLRQVRUXVHGIRULPPXQREORWV 61 
For immunoblotting, gels were transferred to an Millipore Immobilon-P 0.45 µm 62 
polyvinyl fluoride (PVDF) membrane in NuPAGE transfer buffer (Invitrogen) for 60 min at 30 63 
V in a XCell blot module (Invitrogen) and the membrane was then incubated in blocking 64 
solution (TBS-T; 20 mM Tris-Cl, 150 mM NaCl, 0.02% (v/v) Tween-20, pH 7.6 supplemented 65 
with 2% (w/v) ECL Advance blocking reagent; GE Healthcare) for 1 h. All incubation steps 66 
were carried out on a rocker table. Blocking agent was discarded and the membrane was 67 
incubated with mouse monoclonal anti-FLAG M2-peroxidase (HRP) antibody (Sigma; diluted 68 
to 1׷1,000 in blocking solution). Membranes were washed for 3 x 5 min in TBS-T then 69 
incubated for 5 min in ECL substrate consisting of 0.5 ml each of SuperSignal West Dura 70 
reagent A and B (Thermo Scientific) and imaged using a Versa-Doc Imaging system 71 
(BioRad). For quantitative immunoblots, images were analysed using Image Lab 3.0 72 
software (BioRad) for quantification of proteins. 73 
 74 
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Thylakoid membrane preparation. To prepare membranes enriched in thylakoids, cells 75 
from 40 ml cultures were harvested by centrifugation as described above and the pellet was 76 
re-suspended in 25 mM potassium phosphate buffer pH 7.4 with 100 mM NaCl and 10 mM 77 
MgCl2. An equal volume of 0.1 mm zirconium beads was added and the cells were subjected 78 
to 8 pulses of bead beating for 20 s in a Mini-beadbeater-16 (Biospec Products), with 2 min 79 
intervals of incubation on ice between the pulses. The liquid fraction was centrifuged for 1 80 
min at 2000 g at RT to remove contaminating beads and the cell lysate was loaded onto a 81 
step sucrose gradient made from solutions of 30 % (w/v) and of 50 % (w/v) sucrose. The 82 
gradient was made in a SW41 centrifuge tube and the cell lysate was loaded on top of the 83 
gradient and then centrifuged at 154,000 g in an SW41 rotor for 30 min at 4 oC. The 84 
membrane band was harvested using a peristaltic pump and analysed by immunoblotting as 85 
described above.  86 
 87 
Dry cell weight determination. Cell density was measured with a spectrophotometer 88 
(model 7315 by Jenway) at a wavelength of 730 nm. The relationship between OD730 nm and 89 
dry cell weight was determined from a 140 ml culture grown under standard conditions to 90 
OD730 nm of 0.716. Three 40 ml samples were taken from this culture for dry cell weight 91 
determination. Cells were harvested by centrifugation for 10 min at 3,500 g at RT. The 92 
supernatant was removed and the cells were washed with 1 ml of PBS. The cell suspension 93 
was transferred to pre-weighed 1.5 ml tubes and centrifuged again for 5 min at 3,500 g at 94 
RT. The supernatant was aspirated and the cell pellets were dried at 80 °C for 24 h and 95 
were weighed after cooling in a desiccator.  The amount of cells in a litre at one absorbance 96 
unit at 730 nm corresponds to 0.258 gdcw. 97 
 98 
Chlorophyll-a measurement. One millilitre of a cell suspension at an absorbance of 1 at 99 
OD730 nm was pelleted by centrifugation at 3,500 g for 10 min at RT. Cells were re-suspended 100 
in 100 µl of H2O then incubated in 900 µl of acetone overnight at 4 °C in the dark. The 101 
5 
 
extract was centrifuged at 17,000 g for 5 min at RT to pellet debris, the supernatant was 102 
removed and fluorescence was then measured according to Welschmeyer et al (1994).34 103 
 104 
Supplementary figure 1. Quantification of CYP1A1. (a) Immunoblot with 30 µg of total 105 
protein from Sy21 in triplicate and the BAP-FLAG standard at different concentrations. (b) 106 
Plot of BAP-FLAG signal from panel A to generate standard curve for CYP1A1 107 
quantification. The concentration of CYP1A1 was determined to be 6.2 pmol mg-1 total 108 
protein. 109 
 110 
Supplementary figure 27KHLQKLELWRUĮ-naphthoflavone abolishes CYP1A1 activity. 111 
CYP1A1 activity was measured via an EROD (ethoxyresorufin O-deethylation) assay in live 112 
cells using a microplate reader. Measurements were made on three biological replicates 1 h 113 
after the addition of 5 µM of the substrate ethoxyresorufin. The experiment was repeated 114 
three times and results from a typical experiment are shown. Error bars represent the 115 
standard error of triplicate measurements. Statistical significances were inferred by the 116 
6WXGHQW¶Vt test; ***P $GGLWLRQRI0Į-naphthoflavone reduced EROD by 92.9%.  117 
 118 
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